You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

GSK Pharma announces dull Q4 result

Business Finance

Capital Market 

GlaxoSmithKline (GSK) Pharmaceuticals reported 5.95% fall in consolidated net profit to Rs 138.07 crore on 2.5% fall in total income to Rs 802.89 crore in Q4 March 2020 over Q4 March 2019.

The announcement was made after market hours yesterday, 18 May 2020. Shares of GlaxoSmithKline Pharmaceuticals fell 2.05% to close at Rs 1,364.40 on 18 May 2020.

The board of directors recommend a dividend of Rs 40 per equity share which includes a special dividend of Rs 20 per share for this year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 19 2020. 08:25 IST